The clinical outcome of adjuvant therapy with black seed oil on intractable paediatric seizures: A pilot study

Epileptic Disorders

Volumn 15, Issue 3, 2013, Pages 295-301

  Shawki, May ^a   El Wakeel, Lamia Mohamed ^a   Shatla, Rania ^b   El Saeed, Gamila ^c   Ibrahim, Samira ^c   Badary, Osama ^a  

^a African Union Organization St Abbassia   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Black seed oil; Intractable epilepsy; Oxidative stress

Indexed keywords

ANTIOXIDANT; BARAKA; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; LAMOTRIGINE; MALONALDEHYDE; NIGELLA SATIVA EXTRACT; PHENOBARBITAL; PHENYTOIN; PLACEBO; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID;

ADD ON THERAPY; ADOLESCENT; ARTICLE; BLACK CUMIN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; FEMALE; HUMAN; INTRACTABLE EPILEPSY; MALE; NEUROLOGIC EXAMINATION; OXIDATIVE STRESS; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; AGE OF ONSET; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; NEUROLOGIC EXAMINATION; NIGELLA SATIVA; OXIDATIVE STRESS; PLANT OILS; PROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 84884698729     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2013.0602     Document Type: Article

References (51)

1. Abdel-Wahhab MA, Aly SE. Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis. J Appl Toxicol 2005; 25: 218-23. (Pubitemid 40806343)
2. Akhondian J, Parsa A, Rakhshande H. The effect of Nigella sativa L. (black cumin seed) on intractable pediatric seizures. Med Sci Monit 2007; 13: CR555-9. (Pubitemid 350272881)
3. Akhondian J, Kianifar H, Raoofziaee M, Moayedpour A, Toosi MB, Khajedaluee M. The effect of thymoquinone on intractable pediatric seizures (pilot study). Epilepsy Res 2011; 93: 39-43.
4. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003; 17: 299-305. (Pubitemid 36565330)
5. Appleton RE. Seizure-related injuries in children with newly diagnosed and untreated epilepsy. Epilepsia 2002; 43: 764-7. (Pubitemid 34774260)
6. Arhan E, Serdaroglu A, Ozturk B, et al. Effects of epilepsy and antiepileptic drugs on nitric oxide, lipid peroxidation and xanthine oxidase system in children with idiopathic epilepsy. Seizure 2011; 20: 138-42.
7. Aycicek A, Iscan A. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children. Eur Neurol 2007; 57: 65-9.
8. Badary OA, Taha RA, Gamal el-Din AM, Abdel-Wahab MH. Thymoquinone is a potent superoxide anion scavenger. Drug Chem Toxicol 2003; 26: 87-98.
9. Ben-Menachem E, Kyllerman M, Marklund S. Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Epilepsy Res 2000; 40: 33-9. (Pubitemid 30193360)
10. Boskabady MH, Javan H, Sajady M, Rakhshandeh H. The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients. Fundam Clin Pharmacol 2007; 21: 559-66. (Pubitemid 47404328)
11. Duncan JS, Sander JW. The Chalfont Seizure Severity Scale. J Neurol Neurosurg Psychiatry 1991; 54: 873-6.
12. Ekinci O, Titus JB, Rodopman AA, Berkem M, Trevathan E. Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment. Epilepsy Behav 2009; 14: 8-18.
13. Elger CE, Schmidt D. Modern management of epilepsy: a practical approach. Epilepsy Behav 2008; 12: 501-39.
14. Ercegovac M, Jovic N, Simic T, et al. Byproducts of protein, lipid and DNA oxidative damage and antioxidant enzyme activities in seizure. Seizure 2010; 19: 205-10.
15. Ezz HS, Khadrawy YA, Noor NA. The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate. Neurochem Res 2011; 36: 2195-204.
16. Frantseva MV, Perez Velazquez JL, Tsoraklidis G, et al. Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy. Neuroscience 2000; 97: 431-5. (Pubitemid 30320750)
17. Gargari B, Attary VE, Rafraf M, Gorbani A. Effect of dietary supplementation with Nigella sativa L. on serum lipid profile, lipid peroxidation and antioxidant defense system in hyperlipidemic rabbits. J Med Plants Res 2009; 3: 815-21.
18. Ghiselli A, Serafini M, Natella F, Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000; 29: 1106-14.
19. Ghosheh OA, Houdi AA, Crooks PA. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J Pharm Biomed Anal 1999; 19: 757-62. (Pubitemid 29092778)
20. Gluck MR, Jayatilleke E, Shaw S, Rowan AJ, Haroutunian V. CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy. Epilepsy Res 2000; 39: 63-71. (Pubitemid 30053124)
21. Gunes S, Dirik E, Yis U, et al. Oxidant status in children after febrile seizures. Pediatr Neurol 2009; 40: 47-9.
22. Hamed SA, Abdellah MM, El-Melegy N. Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients. J Pharmacol Sci 2004; 96: 465-73. (Pubitemid 40144068)
23. Hosseinzadeh H, Parvardeh S, Asl MN, Sadeghnia HR, Ziaee T. Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus. Phytomedicine 2007; 14: 621-7. (Pubitemid 47176407)
24. Houghton PJ, Zarka R, de las Heras B, Hoult JR. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995; 61: 33-6.
25. ILAE. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981; 22: 489-501.
26. Ilhan A, Gurel A, Armutcu F, Kamisli S, Iraz M. Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice. Neuropharmacology 2005; 49: 456-64. (Pubitemid 41169970)
27. Kalus U, Pruss A, Bystron J, et al. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother Res 2003; 17: 1209-14. (Pubitemid 38057181)
28. Kanter M, Coskun O, Uysal H. The antioxidative and antihistaminic effect of Nigella sativa and its major constituent, thymoquinone on ethanol-induced gastric mucosal damage. Arch Toxicol 2006; 80: 217-24.
29. Khan N, Sharma S, Sultana S. Nigella sativa (black cumin) ameliorates potassium bromate-induced early events of carcinogenesis: diminution of oxidative stress. Hum Exp Toxicol 2003; 22: 193-203. (Pubitemid 36582595)
30. Kruk I, Michalska T, Lichszteld K, Kladna A, Aboul-Enein HY. The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere 2000; 41: 1059-64. (Pubitemid 30390037)
31. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069-77.
32. Lhatoo SD, Langan Y, Sander JW. Sudden unexpected death in epilepsy. Postgrad Med J 1999; 75: 706-9.
33. Lopez J, Gonzalez ME, Lorigados L, Morales L, Riveron G, Bauza JY. Oxidative stress markers in surgically treated patients with refractory epilepsy. Clin Biochem 2007; 40: 292-8.
34. Mansour MA, Ginawi OT, El-Hadiyah T, El-Khatib AS, Al-Shabanah OA, Al-Sawaf HA. Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone. Res Commun Mol Pathol Pharmacol 2001; 110: 239-51. (Pubitemid 36531687)
35. Meador KJ. Cognitive outcomes and predictive factors in epilepsy. Neurology 2002; 58: S21-6. (Pubitemid 34415367)
36. Nagi MN, Alam K, Badary OA, al-Shabanah OA, al-Sawaf HA, al-Bekairi AM. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int 1999; 47: 153-9. (Pubitemid 29112715)
37. Najmi A, Haque SF, Naseeruddin M, Khan RA. Effect of Nigella Sativa oil on various clinical and biochemical parameters of metabolic syndrome. Int J Diabetes & Metabolism 2008; 16: 85-7.
38. Noor NA, Aboul Ezz HS, Faraag AR, Khadrawy YA. Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Epilepsy Behav 2012; 24: 199-206.
39. Richens A. Proof of efficacy trials: cross-over versus parallel-group. Epilepsy Res 2001; 45: 43-7; discussion: 49-51.
40. Sabzghabaee AM, Dianatkhah M, Sarrafzadegan N, Asgary S, Ghannadi A. Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial. Med Arh 2012; 66: 198-200.
41. Salem EM, Yar T, Bamosa AO, et al. Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. Saudi J Gastroenterol 2010; 16: 207-14.
42. Schmidt D, Loscher W. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 2005; 46: 858-77. (Pubitemid 40847354)
43. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997; 82: 291-5. (Pubitemid 27182306)
44. Singh R, Pathak DN. Lipid peroxidation and glutathione peroxidase, glutathione reductase, superoxide dismutase, catalase, and glucose-6-phosphate dehydrogenase activities in FeCl3-induced epileptogenic foci in the rat brain. Epilepsia 1990; 31: 15-26. (Pubitemid 20061081)
45. Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants in epilepsy. Clin Chim Acta 2001; 303: 19-24. (Pubitemid 32121801)
46. Sultan MT, Butt MS, Anjum FM, Jamil A, Akhtar S, Nasir M. Nutritional profile of indigenous cultivar of black cumin seeds and antioxidant potential of its fixed and essential oil. Pak J Bot 2009; 41: 1321-30.
47. Surekha TN, Melinkeri RR. Oxidative and antioxidative status in epilepsy. Pravara Med Rev 2010; 5: 8-10.
48. Turkdogan D, Toplan S, Karakoc Y. Lipid peroxidation and antioxidative enzyme activities in childhood epilepsy. J Child Neurol 2002; 17: 673-6. (Pubitemid 36054404)
49. Ueda Y, Yokoyama H, Niwa R, Konaka R, Ohya-Nishiguchi H, Kamada H. Generation of lipid radicals in the hippocampal extracellular space during kainic acid-induced seizures in rats. Epilepsy Res 1997; 26: 329-33. (Pubitemid 27117808)
50. Verrotti A, Scardapane A, Franzoni E, Manco R, Chiarelli F. Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res 2008; 78: 171-7.
51. Waldbaum S, Patel M. Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res 2010; 88: 23-45.